Clinical Trial Update: A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the effect and safety of the antiemetic casopitant (GW679769) when co-administered with warfarin in healthy volunteers to assess poten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Warfarin (warfarin)
• casopitant (casopitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Chemotherapy-Induced | Phase 1 | Status: COMPLETED